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ABSTRACT
Malignant mesothelioma (MM) is one of the worst cancers in terms of clinical 
outcome, urging the need to establish and characterize new preclinical tools for 
investigation of the tumorigenic process, improvement of early diagnosis and 
evaluation of new therapeutic strategies. For these purposes, we characterized a 
collection of 27 cell lines established from F344 rats, after 136 to 415 days of induction 
with crocidolite asbestos administered intraperitoneally. Four mesotheliomas were 
distinguished from 23 preneoplastic mesothelial cell lines (PN) according to their 
propensity to generate tumors after orthotopic transplantation into syngeneic rats, 
their growth pattern, and the expression profile of three genes. PN cell lines were 
further discriminated into groups / subgroups according to morphology in culture 
and the expression profiles of 14 additional genes. This approach was completed 
by analysis of positive and negative immunohistochemical MM markers in the four 
tumors, of karyotype alterations in the most aggressive MM cell line in comparison 
with a PN epithelioid cell line, and of human normal mesothelial and mesothelioma 
cells and a tissue array. Our results showed that both the rat and human MM cell lines 
shared in common a dramatic decrease in the relative expression of Cdkn2a and of 
epigenetic regulators, in comparison with PN and normal human mesothelial cells, 
respectively. In particular, we identified the involvement of the relative expression 
of the Ten-Eleven Translocation (TET) family of dioxygenases and Dnmt3a in relation 
to the 5-hydroxymethylcytosine level in malignant transformation and the acquisition 
of metastatic potential.
INTRODUCTION
Malignant mesothelioma (MM) is a rare, aggressive 
cancer mainly related to asbestos exposure [1], the 
long latency time between exposure and occurrence of 
clinical symptoms limiting the efficacy of therapeutic 
interventions. Given its chemoresistance, current therapies 
have a negligible impact on overall survival due to a 
lack of understanding of the complex biology of MM 
[2]. Thus, a better understanding of the different steps 
in the development of this disease should be of great 
interest for the identification of early markers of MM 
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and of other potential therapeutic targets. In addition, to 
improve the evaluation of new therapeutic strategies, well-
characterized and highly relevant preclinical MM models 
are urgently required.
Cell lines are universal model systems in cancer 
research and their characterization has provided crucial 
insights into the mechanisms leading to malignant 
transformation. Nevertheless, only a small number of cell 
lines meet the minimum standards of authentication and 
characterization [3], emphasizing the need to avoid the 
use of cultures at high passage levels [4]. Preneoplastic 
cells represent crucial elements in understanding the 
timing and sequence of events that lead to neoplastic 
transformation. Downregulation of E-cadherin was 
observed in the preneoplastic lesions of a rat model of 
lung carcinogenesis, which preceded the occurrence of 
the epithelial-to-mesenchymal transition (EMT) [5], a 
key feature of the process of evading growth suppressors. 
Among the new hallmarks identified during the last 
decade [6], deregulation of cellular energetics, such as 
local hyperinsulinism, has also been identified to lead 
to the development of preneoplastic lesions [7], while 
other reports have demonstrated links between glucose 
metabolism and epigenetic regulator function [8].
The last decade has also been characterized by a 
considerable improvement in our understanding of the 
consequences of epigenomic disruption on the genesis 
of cancer [9]. Among the multiple epigenetic regulators 
associated with gene repression, the Ten-Eleven 
Translocation (TET) family of dioxygenases, which 
catalyze the conversion of 5-methylcytosine (mC) to 
5-hydroxymethylcytosine (hmC), have received much 
attention. hmC levels were also found to be remarkably 
depleted in different human cancer tissues relative to their 
normal counterparts [10], while TET1 was downregulated 
[11]. Recent reports have suggested that TET2 could be the 
major function affected in myeloid disorders and that loss 
of TET2 catalytic function might promote leukemogenesis 
[12]. To date, all studies investigating hmC levels and/
or TET expression have systematically compared tumor 
tissues from various origins relative to their normal 
counterparts. In all cases, the reduced levels of hmC 
in tumor tissues were associated with a decrease in the 
relative expression of all three TET genes when compared 
with their matched normal tissues [13]. To shed light on 
the earlier stages of carcinogenesis, a pioneering study 
demonstrated a significant correlation between changes in 
the three epigenetic components in a rat model of estrogen-
induced breast carcinogenesis [14]. Subsequently, the role 
of polycomb proteins as epigenetic silencers was shown in 
preneoplastic states in the pancreas of mice and rats [15], 
while other epigenetic alterations were documented during 
early stages of hepatocarcinogenesis in rats [16].
To date, the exploration of epigenetic changes, and 
their connection with other molecular events associated 
with the different steps from early preneoplastic lesions to 
malignant transformation and the acquisition of invasive 
properties, have not as yet been documented. In this study, 
the experimental approach used was based on, firstly, the 
characterization of a new collection of both neoplastic 
and preneoplastic mesothelial cells, established from an 
inbred strain of rats induced with asbestos, representing 
different stages in the tumorigenesis process. Secondly, 
among the preneoplastic cell lines, different groups and 
subgroups were identified according to the expression 
profiles of markers. This approach specifically revealed 
new findings related to the involvement of the relative 
expression of TETs and Dnmts in relation to the 5-hmC 
level, in the context of malignant transformation and the 
acquisition of metastatic potential, both in rat and human 
mesothelioma cells.
RESULTS
Rat mesothelial cell lines can be distinguished 
in two main categories: preneoplastic and 
neoplastic
Cell lines were initially distinguished as 
preneoplastic (“PN”, n = 23) or neoplastic (“N”, n = 4) 
according to: observations at necropsy on the individual 
rats from which each cell line was established, cell 
morphology in culture, and propensity or not to produce 
tumors 2 months after orthotopic transplantation of 5 x 106
cells to syngeneic rats (Figure 1A). This discrimination 
was further confirmed by the analysis of expression 
profiles, growth patterns, and determination of the levels 
of cytosine methylation and hydroxymethylation. Analysis 
of Cdkn2a gene mRNA levels by qRT PCR revealed a 
significantly decreased relative expression in neoplastic 
relative to preneoplastic rat cell lines (Figure 2A, left). 
In human cell lines, the expression of Cdkn2a was also 
considerably decreased in pleural mesothelioma (MPM) 
relative to normal mesothelial cells (MC) (Figure 2A, 
right). A very significant decrease in the relative expression 
of Smad3 and increase in the relative expression of Lgals3 
was also observed in neoplastic relative to preneoplastic 
rat cell lines (Figures 2B and 2C). Overall, compared 
with preneoplastic cell lines, neoplastic cells lines were 
characterized by a shorter mean doubling time (Figure 2D 
and supplemental Table S1), a higher proportion of cells in 
S phase (Figure 2E) and a higher saturation density (Figure 
2F and supplemental Table S1). Cell migration analysis 
by scratching test did not reveal any difference between 
categories and groups of cell lines (supplemental Figure 
S1). As many solid malignant tumors show a dramatic 
decrease in their DNA methylation level relative to normal 
tisues, we analysed by dot blot the global methylation 
level in the two categories of cell lines and found that the 
level of cytosine methylation did not differ significantly 
between preneoplastic and neoplastic cell lines (Figure 
2G). However, a very significant difference in the level 
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of hydroxymethylation was observed, revealing an 
implication of this parameter during the tumorigenic 
process (Figure 2H).
Among preneoplastic cell lines, two main groups 
were identified according to the expression 
profiles of eight genes and cell morphology in 
culture
The 23 preneoplastic cell lines comprised two main 
groups, differing in their general “epithelioid” (named PN-
[Epith]) and “sarcomatoid” (named PNsarc) morphology 
in culture (supplemental Figure S2). This observation was 
associated with differences in the expression profiles of 8 
genes (Figure 3A). Analysis of mRNA levels revealed a 
highly significant decreased expression of genes coding for 
podoplanin, ezrin, mesothelin, and Hmgb1 (Figures 3A, 3B), 
and increased expression of genes coding for Rassf1a and 
Zeb1 in the PNsarc group relative to the PN-[Epith] group 
(Figure 3A, 3C). These two main groups also differed by a 
significant increase and decrease in the relative expression 
of the genes coding for vimentin and WT-1, respectively 
(Figure 3D). The identification of the PNsarc group of 9 cell 
lines was confirmed by an increased expression of genes 
coding for the mesenchymal marker alpha smooth muscle 
actin (α-SMA), and TGFβ, an inducer of the epithelial-to-
mesenchymal transition (EMT), relative to the 10 cell lines 
of the PN-[Epith]) group (Figure 4). Finally, a third group 
of 4 cell lines, which shared with PNsarc a low and high 
mean mRNA level for the genes coding for podoplanin and 
Rassf1a, respectively, presented intermediate expression 
levels for other genes (Figures 3A–3D). This group was also 
characterized by an important dispersion of mRNA levels 
for the ten genes evaluated, relative to the PNsarc group, and 
very different morphological characteristics in culture. For 
all these reasons, this group was defined as “miscellaneous” 
(named PNmisc).
Among the preneoplastic cell lines with 
epithelioid morphology, three subgroups were 
identified according to the expression profiles of 
four additional genes
Among the preneoplastic cell lines with epithelial 
morphology, a first subgroup (named subnormal, “Subnl”) 
was identified by the highest expression of c-Myc, a proto-
oncogene gene the deregulation of which contributes to 
deregulated DNA synthesis and genomic instability, and the 
lowest expression of Igf1, a gene involved in the deregulation 
of cellular energetics (Figure 4A). A second subgroup 
of cell lines (named PNep) differed from the former by a 
dramatic increase in the expression of Igf1 and Il10, coding 
for an anti-inflammatory cytokine, and a reduction in the 
mean expression of Cdh1, coding for the epithelial marker, 
E-cadherin (Figure 4B). Finally, a third subgroup of two cell 
lines, named PNint, represented an intermediate situation 
between the PNep and PNsarc subgroups, based on the 
relative expression of Cdh1, Acta2 and Tgfb1 (Figure 4B).
Characterization of the neoplastic cell lines and 
tumors
The four different neoplastic cell lines shared in 
common a significant decrease in the expression of Ezr
and Hmgb1, compared with the PN-[Epith] group of 
preneoplastic cell lines, however their expression profile 
was comparable to that of the PNsarc group (supplemental 
Table S2). Among the four neoplastic cell lines, three, 
F4-T2, F5-T1 and M5-T1 differed by a lower expression 
of Cdkn2a, Rassf1 and wt1, and a higher expression of 
Figure 1: (A) Establishment of the preneoplastic and neoplastic cell lines in F344 rats. Scheme of establishment of the 27 
cell lines and the four preclinical MM models.
Oncotarget4www.impactjournals.com/oncotarget
Msln, Pdpn, Acta2, Zeb1 and Tgfb1, compared with 
M5-T2, (supplemental Table S2), and a propensity to 
produce metastases in different normal tissues after 
orthotopic transplantation into syngeneic rats. The M5-
T2 tumor differed from the three others by the absence 
of metastatic potential, with tumor cell development 
restricted to the omentum. In vitro, the M5-T2 cell 
line was also characterized by a low saturation density 
(supplemental Table S1). In contrast, the most aggressive 
neoplastic cell line, M5-T1, presented a specific growth 
pattern, characterized by the shortest doubling time, 
and the highest saturation density (supplemental Table 
S1). Cell cycle analyses revealed that this cell line 
showed the highest percentage of cells in S phase, the 
presence of a tetraploid population, and sphere forming 
capacity in culture (supplemental Figure S3). These 
observations contrasted with the proportion of cells in the 
different phases in the diploid F3-1 cell line, chosen as 
representative of the PNep subgroup of preneoplastic cell 
lines.
Characterization of the four tumor models by 
immunohistochemical markers revealed that, although 
Figure 2: RT-PCR analysis of the relative expression of genes discriminating preneoplastic and neoplastic rat 
mesothelial cell lines. A. Cdkn2a (p 16), in the rat experimental biocollection of cell lines (left) and the human biocollection of cell lines 
(right). MC, normal mesothelial cells; MPM, malignant pleural mesothelioma cells. B. Smad3 and C. Lgals3.
(Continued)
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Figure 2 (Continued):  Growth characteristics of the rat cell lines in culture, mean doubling time D. proportion of cells in S phase E., 
and mean saturation density F. Levels of methylation G. and hydroxymethylation H. determined by dot blot. Signals were quantified for 
each subgroup of cell lines and normalized to the intensity of the corresponding gel red signal.
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the staining was moderate and heterogeneous, all tumor 
cells exhibited positivity for WT1, a common positive 
mesothelioma marker (Figure 5A). On the other hand, 
all tumor cells were negative for ESA/EPCAM/(MOC 
31) (Figure 5B), a negative mesothelioma marker 
commonly used to distinguish mesotheliomas from 
carcinomas. Comparison between immunostaining for 
calretinin and vimentin in a liver metastasis of M5-T1, 
the most aggressive tumor, revealed a contrast between a 
moderate, overall homogeneous positivity of tumor cells 
for calretinin, and the presence of foci of cells strongly 
positive for vimentin close to the tumor front (Figure 5C).
To characterize the chromosomal events potentially 
associated with the molecular changes, complete spectral 
karyotypes and karyotypic formulas were analyzed for M5-
T1 in comparison with the F3-1 cell line (supplemental 
Figure S4 and supplemental Table S3). The unique 
structural rearrangement observed in the F3-1 cell line 
was a der(15)t(1;15)(q?41 ;q2?2), leading to a distal gain 
of chromosome 1 in 15% of metaphases (Figure 4A, 4D). 
Fifty-nine percent of F3-1 metaphases displayed a normal 
karyotype (42, XX) and 21% of metaphases had a modal 
chromosome number of 41. Compared with the F3-1 
cell line, the study of ploidy in M5-T1 cells revealed the 
presence of two subpopulations in accordance with cell 
cycle analysis by flow cytometry (supplemental Figure 
S3). A near-diploid population representing about 61% of 
the total metaphases analyzed had a modal chromosome 
number of 43. The tetraploid population represented about 
39% of the total metaphases and had a modal chromosome 
number of 86. The M5-T1 near-diploid population retained 
the structural abnormality der(15)t(1;15) in two metaphases 
only, but, interestingly, chromosome 15 was also found to 
be fused to chromosome 2, and once with chromosome 4, 
Figure 3: RT-PCR analysis of the expression of genes discriminating the different groups of preneoplastic rat 
mesothelial cell lines. A. Heatmap of expression profiles of the preneoplastic rat cell lines.
(Continued)
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Figure 3 (Continued):  Genes coding for B. podoplanin (Pdpn), ezrin (Ezr), mesothelin (Msln), HMGB1 (Hmgb1); C. RASSF1A 
(Rassf1), ZEB1 (Zeb1); D. vimentin (Vim), and WT1 (Wt1).
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Figure 4: RT-PCR analysis of the expression of genes discriminating the different subgroups of epithelioid preneoplastic 
rat mesothelial cell lines. Genes coding for A. c-Myc (Myc) and IGF-1 (Igf1); B. E-cadherin (Cdh1), α-smooth muscle actin (α-SMA) 
(Acta2), TGFβ (Tgfb1), and IL-10 (Il10).
AU 2
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Figure 5: Immunohistochemical characterization of rat mesotheliomas. Immunohistochemical staining for WT1 A. ESA/
EPCAM (MOC 31) B.
(Continued)
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Figure 5 (Continued):  vimentin C. of the tumors collected from syngeneic F344 rats after i.p. injection of the neoplastic rat cell lines 
M5-T1, F5-T1, F4-T2 and M5-T2, x 800, the scale bars represent 25 μm. Inserts show general views, x25, the scale bars represent 1 mm 
and the red arrow indicate the location of the magnification. Pa, pancreas; T, tumor; D, duodenum; L, liver; O, omentum. D. Comparison of 
IHC staining for calretinin (left) and vimentin (right) in a liver metastasis of M5-T1. Top, x 100, the scale bars represent 250 μm; bottom, 
x 800, the scale bars represent 25 μm; red arrows indicate foci of tumor cells exhibiting strong positivity of vimentin at the tumor front. 
Hp, hepatocytes.
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Figure 6: RT-PCR analysis of the relative expression of the three DNA methyltransferase genes. Rat (left column) and 
human (right column) cell lines.
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Figure 7: RT-PCR analysis of the relative expression of the three Ten-Eleven Translocation (TET) dioxygenase genes.
Rat (left column) and human (right column) cell lines.
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in the tetraploid metaphases with the same breakpoint on 
chromosome 15 (supplemental Figure 4D). Otherwise, no 
more metaphases with normal karyotypes were observed 
and all the chromosomes except chromosomes 7 and 
16 were involved in either numerical alterations and/or 
structural alterations such as translocations and deletions. 
The major recurrent alteration was deletion of chromosome 
5 (82% of all M5-T1 metaphases).
Changes in the expression of epigenetic 
regulators and 5-hmC levels in rat and human 
mesothelial cell lines and mesotheliomas
During the past decade, a number of studies 
investigating the role of epigenetics in cancer development 
have revealed altered hmC levels and/or TET and/or 
DNMT gene expression in human tumor tissues relative 
to their normal counterparts [9–13]. We previously 
showed a significant decrease in the global level of the 
5-hydroxymethylcytosine, but not 5-methylcytosine 
between preneoplastic and neoplastic cell lines (Figure 
2G, 2H). To confirm this both in rat and human MM cell 
lines, we investigated the changes in the expression of 
all these epigenetic regulators and tried to shed light in 
parallel on events occurring in preneoplastic mesothelial 
cells, an element that has never been documented.
Dnmt3a expression showed a significant decrease 
in neoplastic compared to preneoplastic cells in both rat 
and human mesothelial cell lines (Figure 6). A significant 
decrease in the expression of Dnmt3b was also observed in 
the rat. In parallel, a decrease in the expression of all TET 
genes was observed in both species (Figure 7). However, 
this decrease was significant in the rat for TET1 and TET3 
between preneoplastic and neoplastic cell lines (Figure 
7), and in humans for TET2 between normal mesothelial 
cells (MC) and malignant pleural mesothelioma cell lines 
(MPM) (Figure 7). Of the four neoplastic rat cell lines, 
M5-T1 also presented the lowest expression of TET3 
(117.5 vs. 255.5, 287.3, and 863.9 for the three others). 
Finally, among preneoplastic rat cell lines, a significant 
decrease in the expression of Dnmt3b and all TET genes 
was observed in the three invasive neoplastic cell lines, 
relative to the PNsarc group (supplemental Figure S5).
Representative images of the M5-T1, F5-T1, F4-
T2 and M5-T2 tumors (HPS staining of detailed views 
in Figure 8A, left column, general views in supplemental 
Figure S6) globally reveal low levels of staining for 
5-hmC, which contrasts with the strong nuclear signals 
observed in the vicinal normal liver tissue (Figure 8A, 
right column). Conversely, in agreement with methylation 
levels on dot blots (Figure 2G), immunohistochemistry for 
5-mC on the same sections showed equivalent levels of 
staining in tumor and normal liver. Quantification of the 
staining intensity for 5-hmC in tumor vs. liver revealed 
marked differences between the four different tumor types, 
with M5-T1 exhibiting the highest ratio (Figure 8B).
Immunohistochemical analysis of 5-hmC levels in 
human tissue microarrays revealed a progressive fall in 
the mean intensity of positive staining between normal 
mesothelial cells, grade I mesothelioma cells, and grade 
II mesothelioma cells. In parallel, the proportion of 
positively stained cells decreased, while the proportion of 
negative cells (in blue) increased (Figure 8C).
DISCUSSION
During development, the mesothelium, which 
consists of a monolayer of specialized cells with a typical 
cobblestone-like morphology, retains its potential to 
differentiate into cells of different phenotypes [17]. This 
mesenchymal “pluripotent” origin of mesothelioma cells 
is suggested to be responsible for the complex biology of 
MM and for the lack of efficacy of current therapies [2]. 
When injured through prolonged contact with fibers such 
as asbestos, mesothelial cells are transformed, move into 
the serosal fluid and thus can be easily isolated, cultured, 
characterized, and for some of them, transplanted into 
laboratory rodents to produce tumors. In this study, we 
took advantage of this diversity of experimental situations 
to establish a collection of cell lines which could 
significantly contribute to understanding some of the 
mechanisms of mesothelioma tumorigenesis.
Expression profiles of three genes discriminate 
all neoplastic from preneoplastic rat mesothelial 
cell lines
Among this biocollection, four cell lines shared in 
common the potential to generate tumors in vivo after 
orthotopic transplantation into the peritoneal cavity of 
syngeneic rats. Our finding that Lgals3 was up-regulated 
at the mRNA level in neoplastic relative to preneoplastic 
cell lines is in good agreement with accumulating evidence 
indicating that galectin-3 is closely involved in tumor cell 
transformation, migration, invasion and metastasis for a 
number of cancers [18, 19]. In addition, the observation of 
a higher expression level of Lgals3 in the three invasive 
neoplastic cell lines compared with the non invasive 
M5-T2 suggests a relation with the tumor grading, as 
previously demonstrated in human gliomas [20].
Cdkn2a also represents a tumor suppressor gene 
that has previously been reported to represent a target for 
biological studies on mesothelioma [1, 21]. Investigations 
on this gene have proven to be a reliable way of separating 
benign from malignant mesothelial proliferations in 
tissues [22], in particular for the sarcomatoid subtype 
[23, 24]. In this study, the expression of Cdkn2a (p16) 
was significantly reduced, both in neoplastic relative 
to preneoplastic cell lines, and in human pleural 
mesothelioma relative to normal human mesothelial 
cells, thus confirming the potential of this gene for the 
diagnosis of MM. Smad3, a gene for which the expression 
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level was dramatically reduced in a tumorigenic cell line 
transformed with activated H-Ras compared with the 
normal parental epithelial cells [25], recently appeared 
to represent an important determinant of the progression 
of tumorigenesis. Herein, the significant decrease in the 
expression of Smad3 observed in all neoplastic relative 
to preneoplastic cell lines is also in good agreement with 
the initial report of Han and colleagues, demonstrating 
that suppression of Smad3 expression occurred in human 
gastric tumor cells in contrast to neighboring normal tissue 
[26].
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Figure 8: Immunohistochemical staining for 5-hmC of rat and human mesotheliomas. A. Histology and immunohistology 
of rat mesotheliomas collected three weeks after i.p. inoculation of the four neoplastic cell lines into syngeneic F344 rats. Left column: HPS 
staining, detailed views of the fields denoted by the red arrows on general views (see supplemental Figure S5), showing the morphology of 
tumor cells invading the liver tissue (M5-T1, F5-T1), attached to it (F4-T2) or growing on the omentum (M5-T2) without metastases in the 
vicinal normal tissues. The scale bars represent 50 μm. Middle column: IHC figures of anti-5-hmC immunostaining of the tumor tissue (left 
part) and liver parenchyma (right part), the scale bars represent 50 μm. Right column: IHC figures of anti-5-mC immunostaining of the tumor 
tissue (left part) and liver parenchyma (right part), the scale bars represent 25 μm. B. Semi-quantification of 5-hmC immunostaining in the 
four rat mesothelioma models. The numbers of positive and negative cells in the tumor tissue and the liver parenchyma were determined 
on five high-magnification fields (x 800) containing both tumor tissue and liver parenchyma (except for the noninvasive M5-T2 cell line).
(Continued)
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Figure 8 (Continued): C. Representative images of normal mesothelial cells of the pleura and pericardium (1, 2, inserts show high 
magnification), and malignant mesothelioma, grade I (3, 4) and grade II (5, 6), stained with an anti-5-hmC antibody, scale bars represent 50 
μm. IHC of normal mesothelial cells of the pleura and pericardium (7, 8, inserts show high magnification), and malignant mesothelioma, 
grade I (9, 10) and grade II (11, 12), stained with an anti-5-mC antibody, scale bars represent 50 μm.
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Characterization of preneoplastic rat mesothelial 
cell lines
To date, most studies on preneoplastic cell lines 
have been conducted either on spontaneously transformed 
normal cells in culture [27] or on immortalized cell 
clones isolated from biopsies [28]. Additional insights 
have been obtained from histopathological observations 
made on both preneoplastic and neoplastic cells [29] and 
by the use of transgenic animals [30]. However, all these 
experimental approaches present important limitations. 
Cell lines selected under in vitro conditions for a long 
period of time present many alterations of specific cellular 
pathways compared with tissues [31]. Data obtained 
from biopsies or/and histopathologic observations from 
patients are limited by the genetic heterogeneity of the 
source materials. Finally, many inbred transgenic and 
targeted mutant mice have been created using animals of 
mixed genetic backgrounds [32]. In contrast with all these 
situations, in our study, the biocollection of cell lines was 
obtained from F344 rats, an inbred strain known for its 
stable genetic background [33], induced with the same 
material at the same age, which is likely to significantly 
limit the number of parameters involved in mesothelioma 
tumorigenesis.
Among the 23 preneoplastic rat mesothelial cell 
lines established, two groups were identified according to 
the expression profiles of eight genes and to morphology 
in culture. The decreased expression of the Msln gene 
observed between the PN-[Epith] and PNsarc groups is 
in good agreement with the differences in the expression 
profiles previously observed at both the mRNA and 
protein levels [34], and with immunohistochemical 
findings reported by Ordóñez [35]. The low level of 
Msln expression in the PNsarc group, in contrast to the 
PN-[Epith] group, could also be due to instability of 
Msln mRNA, according to the presence of a polymorphic 
variant and regulation by micro-RNA [36]. Similarly, 
although podoplanin has been presented as an interesting 
immunohistochemical marker in the diagnosis of 
mesothelioma [37], its expression is frequent in the 
epithelioid subtype but usually absent in the sarcomatoid 
subtype [38, 39], in agreement with our findings on 
PNsarc cell lines. This observation was further confirmed 
in iron-induced high-grade rat MM where only epithelioid 
subtypes were strongly positive for podoplanin [21].
We found a decrease in the expression of the Ezr 
gene, coding for ezrin, a multifunctional membrane 
cytoskeleton linker that regulates the structure and 
function of specific domains of the cell cortex. This could 
be explained by the fact that few microvilli have been 
observed in the sarcomatoid subtype [40], as ezrin was 
originally identified in high amounts in these structures 
[41], an ultrastructural characteristic of normal mesothelial 
cells and epithelioid MM [42]. Regarding Hmgb1 
expression, besides its well-documented proinflammatory 
role, evidence for its restorative effects leading to tissue 
repair and regeneration have previously been reported 
[43]. Thus, the decrease in its expression observed both 
in PNsarc and neoplastic cell lines could participate in 
nuclear instability, in good agreement with the fact that 
its localization in the nucleus maintains nuclear stability 
under stress [44].
Changes among preneoplastic epithelioid rat 
mesothelial cell lines
Among PN-[Epith] cell lines, the first significant 
Cdh1 expression loss occurred between the Sbnl and 
PNep subgroups, preceding the increase in expression 
of both Tgfβ1 and Acta2 in the two PNint cell lines, 
suggesting a link with the EMT process [45]. In parallel, 
the observation of a dramatic increase Igf1 expression 
also agrees with the recent demonstration of the role of 
deregulation of cellular energetics in the development 
of preneoplastic lesions [7], in relation with a very early 
event of cadherin modulation in the oncogenic EMT 
program [46]. Under certain conditions of stimulation, the 
increased production of IL-10 transcript by rat peritoneal 
mesothelial cells has also been shown [47], suggesting 
a relation with an inflammatory process. The dramatic 
change observed in the expression of Myc suggests a link 
with the dynamic process of genomic instability related 
to this oncogene, which has been extensively documented 
during the past two decades [48]. Finally, the elevated 
expression of Tgfb1, Zeb1 and Acta2 and the additional 
loss of expression of Cdh1 also observed between the 
PNep subgroup and the PNsarc group are consistent with 
the dual role that has been reported for Zeb1, a repressor 
of gene transcription with a target gene such as Cdh1, and 
also a transcriptional activator that targets genes such as 
Acta2 [49].
Expression profiles and IHC markers of invasive 
MM rat cell lines share more homology with the 
PNsarc group than does M5-T2, suggesting a 
mesenchymal phenotype
Mesothelioma tumorigenesis involves mesothelial 
progenitor cells [17, 50, 51] able to switch between 
different cell phenotypes in both directions depending 
on the local environment, which can differentiate to 
epithelioid or mesenchymal phenotypes. We previously 
showed that among the four mesothelioma cell lines, 
three exhibited invasive capacities in the Boyden test, 
in agreement with their metastatic potential observed 
in this study [52]. Herein, the dramatic decrease in the 
expression of Pdpn, Ezr, Msln, Hmgb1, Wt1 and Cdh1
shared by these three cell lines and the PNsarc group, 
compared with the PN-[Epith] group, tend to confirm 
that these three cell lines and the PNsarc group present in 
common the characteristics of a mesenchymal phenotype. 
In agreement with previous findings [40], the overall weak 
expression of calretinin and clear positivity for vimentin 
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of tumors generated by these three MM cell lines leads 
to the conclusion that these tumors can be diagnosed as 
sarcomatoid.
In contrast, in the M5-T2 cell line, this common 
decrease was restricted to Ezr, Msln, Hmgb1, and Cdh1, 
the high expression profiles of two genes, Pdpn and Wt1, 
together with the higher percentage of cells strongly 
positive for WT-1 in IHC suggesting the occurrence 
of some reminiscent homologies with the PN-[Epith] 
group. The singular situation of the M5-T2 cell line was 
reinforced by the observation of a maximum expression 
of five other genes, Rassf1, Zeb1, Vim, Acta2 and Tgfb1, 
which was common to the PNsarc group, in contrast with 
the three invasive mesothelioma cell lines which presented 
significantly lower expression levels.
Karyotype alterations and aggressiveness
The comparison of expression profiles with the 
results of karyotype analysis for the M5-T1 cell line allows 
the definition of several points of interest that appear to 
be related to aggressiveness. A recent study confirmed 
that p16 deletion is a good marker of malignancy, both 
in pleural and peritoneal mesotheliomas with invasive 
components [53]. A common chromosomal deletion 
was detected at 5q32, containing the Cdkn2a gene, and 
a homozygous deletion was observed in the majority 
of cases from epithelioid to sarcomatoid and biphasic 
mesotheliomas [54]. The results from our model tend to 
confirm this fact, as M5-T1 cells exhibited the lowest 
level of Cdkn2a expression while spectral karyotyping of 
this cell line revealed a recurrent, large deletion of one 
rat chromosome 5, including the q32 band, in 82% of 
metaphases, suggesting at least loss of heterozygosity for 
Cdkn2a. In the rat, the Pdpn gene is also localized very 
close to Cdkn2a on chromosome 5, at 5q36, where this 
deletion was observed, a point that could also explain the 
lowest Pdpn expression level of this cell line. The dramatic 
decrease observed in the expression of Smad3 could also 
be related to the important deletion of chromosome 8, 
which bears this gene. Finally, the very low expression 
level of Msln specifically observed in the three invasive 
cell lines, in contrast to M5-T2, also appears to be related 
to another deletion occurring on chromosome 10, this the 
Msln gene being localized to 10q12-q21 inthe rat.
Epigenetic regulators and tumorigenesis
Global DNA hypomethylation and locus-specific 
DNA hypermethylation have been identified as key 
features of many cancers [55, 56]. In the specific case of 
mesothelioma, epigenetic dysregulation is now established 
to be a critical mode of action of asbestos, and it has been 
suggested to be associated with inflammation-related 
processes common to several cancers. A large study 
of epigenomic alterations in 158 pleural MM samples 
obtained from human patients revealed hundreds of loci 
that had different methylation levels between tumor and 
non tumor pleura, identifying seven distinct methylation 
subclasses and leading to the idea that asbestos-associated 
inflammation could drive this epigenetic diversity [57]. 
In the latter study, Dnmt3b was mentioned in the list of 
genes having significantly lower methylation in tumors, 
suggesting epigenetic dysregulation. This observation 
presents interesting connections with our findings in 
the rat biocollection of cell lines, a significant decrease 
in the expression of Dnmt3b being observed between 
all preneoplastic and neoplastic cell lines, as well as 
between the PNsarc group and neoplastic cell lines. The 
different evolution observed in the human biocollection 
for the expression of this enzyme, while a common 
pattern of expression profile was observed in the two 
species for Dnmt3a, could also be explained by recent 
reports indicating that the two enzymes have overlapping 
functions and that their roles in cancers may be more 
complex than previously believed [58]. In our study, the 
final fall in expression of de novo Dnmt3a and Dnmt3b
could be explained by the recent demonstration of 
downregulation after induction of EMT by TGFβ in lung 
cancer cells [59]. Our results are also in good agreement 
with the recent finding that both de novo DNMTs showed 
a different pattern of expression relative to DNMT1 during 
carcinogenesis, with an overexpression in early cancer 
stages and a final reduced expression in tumors [60]. Thus, 
this event could represent the situation found in MM with 
the worst outcome. The involvement of DNA methylation 
in EMT has also been documented, hypermethylation of 
the promoter region being one of the key factors leading 
to a reduced mRNA expression of Cdh1 during EMT [61]. 
This could contribute to the final fall in the expression of 
Cdh1.
In our study, another striking result concerned 
the parallel evolution of the expression of TET2/TET3
and Dnmt3a/Dnmt3b. So far, although TET3 has been 
considered to be the most important regulator [62], 
relationships between TET3 and cancer have been poorly 
investigated. A recent study demonstrated that the low 
level of 5-hmC observed in carcinoma in situ cells (CIS) 
of the testis corresponded to the absence of expression of 
TETs in these cells, especially TET3 [63]. We observed 
here that the most aggressive MM cell line, M5-T1, 
showed the lowest expression of TET3, an observation that 
could be explained by the deletion of the q34-q44 region of 
chromosome 4, which includes the TET3 gene. In addition 
to Cdkn2a on chromosome 5, another observation relating 
karyotypic alterations to aggressiveness concerns the 
NF2 gene coding for merlin, the second major alteration 
in human MM, which was shown to be the target tumor 
suppressor gene of 22q12 loss and found to be mutated 
in the majority of human MM [64]. Interestingly, this 
gene, located on rat chromosome 14q22, was included in 
a deletion observed in 79% of M5-T1 metaphases.
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The parallel lowest expression of Dnmt3b and 
lowest 5-hmC level, especially in the tumor cells located 
at the invading front in the liver tissue, provides the first 
evidence of a clear link between these three epigenetic 
parameters. Evidence of collaboration between TET2 
and TET3 proteins to suppress aberrant hematopoiesis 
and hematopoietic transformation has also been reported 
recently [65]. Interestingly, the parallel between DNMT3A 
and TET2, and their mechanisms of cooperation, have 
been mentioned for future studies [12]. TET2 represents a 
critical regulator for normal and malignant hematopoiesis 
[66], and its expression has recently been shown to 
represent a prognostic factor for colorectal carcinoma 
recurrence and outcome [67]. TET2 expression is also 
significantly associated with 5-hmC levels in esophageal 
squamous cell carcinoma [68].
In conclusion, in this work we present a 
biocollection of rat mesothelial cells at different stages 
of carcinogenesis. The transcriptomic and karyotypic 
characterizations of these rat MM cells showed high 
similarities with human MM cells, highlighting the 
pertinence of our preclinical models for future evaluation 
of new therapeutic strategies. Finally, evaluation of 
this biocollection allowed us to suggest that epigenetic 
alterations, downregulation of TETs and DNMTs and 
a decrease of 5-hmC in tumor cells are all correlated 
with the acquisition of an aggressive phenotype, in good 
agreement with human MM.
MATERIALS AND METHODS
Establishment of experimental rat cell lines
Fischer F344 rats were obtained from Charles River 
Laboratories (L’Arbresle, 69, France) and maintained 
under standard conditions in the UTE IRS-UN animal 
holding area in agreement with European Union 
guidelines for the care and use of laboratory animals in 
research protocols. The experiments were approved by 
the regional ethical committee for animal experiments 
(CEEA.2011.38). Rats were fed a pelleted standard 
diet (RM1, Special Diet Services, Witham, Essex, UK), 
with tap water ad libitum, and were anesthetized via 
an isoflurane chamber (Forene®, Abbott France) and 
euthanized with Dolethal® (Centravet, Pluduno, Plancoët, 
France).
The cell lines used in this study belong to a 
biocollection established in 2011 [https://migratech.
inserm-transfert.fr/srv/tech/2/index100.asp?cl=CL]. To 
establish this biocollection, at 8 weeks of age, a group of 33 
rats (16 males and 17 females) received an intraperitoneal 
inoculation of 10 mg crocidolite fibers suspended in 0.5 
ml 0.9% NaCl (UICC analytical sample, ref. 02704A, 
Neyco, 75017 Paris, France). Between 136 and 415 
days after induction, after euthanasia, 2 ml sterile RPMI 
medium was injected intraperitoneally, the peritoneal 
lavage fluids were collected under sterile conditions and 
then placed into culture. This step led to the establishment 
of 23 transformed mesothelial cell lines. After 378 days 
of induction, one male rat was necropsied about one hour 
after death, presenting signs of hemorrhage, widespread 
neoplastic implants and nodules in the peritoneal cavity as 
previously described [69], which, when dissociated with 
a scalpel and cultured, led to the first neoplastic MM cell 
line M5-T1. During the next two weeks, three additional 
MM cell lines were established from dissociated neoplastic 
implants and nodules were collected on two females and 
one male euthanized rats (F4-T2, F5-T1 and M5-T2). 
These cell lines were distinguished from the former 23 by 
their capacity to produce macroscopic tumors in syngeneic 
F344 rats three weeks after intraperitoneal inoculation of 
5 x 106 cells.
Human cell lines
Mesothelioma cell lines were established from 
pleural effusions collected by thoracocentesis of 
patients with cancers, as previously described [70]. 
All patients provided written informed consent and the 
study was approved by the ethics committee “Comité 
de Protection des Personnes Ouest IV – Nantes, CPP 
N° 877/2011”, CHU de Nantes, France. Isolation and 
culture of normal mesothelial cells from pleura have 
been described previously [70]. Primary peritoneal 
mesothelial cells (PMC) were purchased from Tebu-bio 
biosciences and cultured according to the manufacturer’s 
recommendations.
Cell culture and chemicals
All cell lines were maintained in RPMI 1640 
medium (Invitrogen) supplemented with 10% heat-
inactivated fetal calf serum (Eurobio), 100 U/ml penicillin, 
0.1 mg/ml streptomycin, 2 mM L-Glutamine (Sigma-
Aldrich, St Louis, MO, USA) and cultured at low passage 
level (6 to 10) in a humidified atmosphere of 5% CO2 at 
37°C.
Proliferation assays and cell cycle analysis
For determination of the population doubling time 
in the mid-log phase and the saturation density at plateau, 
in order to approach the conditions of proliferation in vivo
after transplantation, cell lines were seeded at 3 x 105 cells/
well at time 0 in 6-well plates (Nunclon delta, Nunc AS, 
Denmark) and counted in a Malassez hemocytometer, 
the entire growth curve being obtained from at least 
12 time points. Cell cycle analysis was conducted on a 
NucleoCounter® NC-3000™ (ChemoMetec, Allerød, 
Denmark) using NC-Slide A8™ after trypsinization, 
centrifugation, fixation of cells with ethanol, and 
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incubation with DAPI at 37°C for 5 minutes. The cell 
number in each phase of the cell cycle was determined 
and calculated as a percentage of the total cell population.
Measurement of cell migration
Cell migration was analyzed for all rat cell lines by 
the scratching test [71]. When cell density was confluent, 
for each cell line cultivated in 12-well plates (3.5 cm2 / 
well), one wound line in the form of a cross was made by 
scratching the cell monolayer with a plastic pipette tip. 
Floating cells were washed out and fresh medium was 
added. The narrowing width of the scratch was recorded 
by taking photographs under an inverted Zeiss Axio 
Observer.Z1 microscope from 17 h after the scratch.
Total RNA isolation and real-time PCR
Total RNA was extracted from one 75 cm2 culture 
plate at preconfluence for each cell line using the 
NucleoSpin RNA II Kit according to the manufacturer’s 
instructions (Macherey-Nagel, Hoerdt, France). The total 
RNAs were next treated with an rDNase solution to remove 
contaminating genomic DNA, and subsequently purified. 
One microgram of total RNA was reverse-transcribed using 
Moloney-Murine Leukemia Virus Reverse-Transcriptase 
(Invitrogen). PCR reactions were performed using an 
Mx4000 thermocycler (Stratagene) with 10X QuantiTect 
Primer Assays (Qiagen), and the RT2 Real-Time SYBR-
Green/ROX PCR Mastermix (tebu-bio, Le Perray-
en-Yvelines, France), according to the manufacturer’s 
instructions. The thermal cycling protocol was followed 
by a melting curve analysis to check for the absence of 
nonspecific products. For each transcript, the efficiency 
of the PCR reaction was determined by the slope of the 
standard curve generated from serial dilutions of the same 
cDNA sample (pool of reverse-transcribed RNA samples). 
The relative amount of target RNA, called the Starting 
Quantity (SQ), was determined using the MxPro software, 
by comparison with the corresponding standard curve for 
each sample performed in duplicate. Each transcript level 
was normalized by division with the expression values of 
the acidic ribosomal phosphoprotein P0 housekeeping gene 
(RPLP0), used as an internal standard.
Tumor samples and immunohistochemistry
For histological examination, the paraformaldehyde-
fixed, paraffin-embedded sections of rat tumor samples 
(M5-T1, F5-T1, F4-T2 and M5-T2), and surrounding 
normal/invaded tissues when present, were cut with a 
Bond Max automaton (Menarini, Rungis, France) and 
stained with hematoxylin-phloxine-saffron (HPS). A 
human mesothelioma array with normal mesothelium 
tissue (lung and cardiac pericardium) was obtained from 
US Biomax Inc. (Rockville, MD, USA). Antibodies 
used for immunohistochemical analyses were anti-WT-1 
ab15249, anti-calretinin ab16694 and anti-vimentin 
ab8978 from Abcam, anti ESA/EPCAM (MOC 31) LS-
C331328 from LSBio, and anti-5-hmC 39769 (1/200) 
and anti-5-mC 61255 (1/60) from Active Motif Europe 
(La Hulpe, Belgium), with an anti-mouse secondary 
antibody and the N-Histofine Simple Stain Mouse MAX 
Peroxidase (Nichirei Biosciences, Tokyo, Japan) as the 
detection reagent. Histopathology slides were scanned 
with a Nanozoomer 2.0 HT (Hamamatsu, Japan). To 
semiquantify histochemical staining on rat tumor slices, 
five randomly selected fields of 27,000 μm2 were analyzed 
both by manual counting and by color deconvolution of 
TIF images using Fiji software and the Otsu method 
[72]. Histochemical staining of the human mesothelioma 
array with anti-5-hmC and anti-5-mC was analyzed on 20 
samples of normal tissue, 20 samples of grade I malignant 
mesothelioma (with tumor invading the submucosa) and 
16 samples of grade II malignant mesothelioma (with 
tumor invading the muscularis propria). The small number 
of samples available on the microarray did not allow an 
analysis of grades III-IV.
Dot blots
DNA samples were denatured by the addition of 
denaturation buffer (0.1 mM NaOH) and subsequently 
heated for 5 minutes at 95°C. The reaction was then 
stopped by addition of 6.6 mM ammonium acetate. 
Samples were rapidly chilled for 5 minutes on wet ice 
and then applied to a positively charged nylon membrane 
(Immobilon-P Transfer, Millipore), previously charged and 
rehydrated by dipping for 15 seconds into ethanol and 5 
minutes in tris-buffered saline with Tween 20 (TBST). The 
membrane was then air dried for 15 minutes. Denatured 
DNA was spotted onto the membrane and air dried for 
45 to 60 minutes, UV-cross-linked to the membrane 
(UV Stratalinker 2400), and incubated for 1 hour with 
saturation buffer (TBST 1%BSA). Primary antibody (5-
hmC dilution 1/10,000; 5-mc dilution 1/5,000, Active 
Motif, La Hulpe, Belgium) was incubated overnight at 
4°C with agitation. The membrane was washed three times 
with TBST and incubated with the anti-rabbit secondary 
antibody (HRPanti IgG, Covalab). The membrane was 
washed again three times with TBST and the signal was 
revealed using enhanced chemiluminescence (ECL) 
substrate (Immobilon western chemiluminescent HRP 
substrate, Millipore) and read with a Biorad Chemidoc 
MP Imaging System. To control the DNA load, DNA was 
quantified using gel red and the membrane was scanned 
with the Biorad imager. Dot blot signals were quantified 
and normalized to the intensity of the corresponding gel 
red signal. To ensure specificity of the antibody, naked 
DNA, methylated DNA, and 5-hmC DNA control (Active 
Motif) were used (data not shown).
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Multicolor FISH (M-FISH)
Metaphases were obtained using standardized 
harvesting protocols as described previously. Briefly, 
colcemid solution (0.03 μg/ml) was added to F3-1 and 
M5-T1 cells 90 minutes and 30 minutes before harvesting, 
respectively. Cells were treated with hypotonic solution 
(0.075M KCl), fixed three times with Carnoy’s fixative 
(3:1 methanol/acetic acid) and spread on prechilled 
glass slides. M-FISH was performed with the aim of 
identifying numerical and structural alterations in both 
cell lines. The probe cocktail containing differentially 
labeled, chromosome-specific painting probes – except 
for chromosomes 13 and 14, which were distinguished 
by their DAPI banding (22XRat kit MetaSystems, 
Altlussheim, Germany) – was denatured and hybridized 
to denatured metaphase spreads according to the 
manufacturer’s protocol for the Multicolor FISH probe kit 
for rat chromosomes (MetaSystems). After counterstaining 
with DAPI (1 μg/ml), the signal detection and analysis 
of subsequent metaphases used the Metafer system and 
Metasytems’ ISIS software, respectively. F3-1 and M5-T1 
karyotypic formulas were reported using an abbreviated 
format of the International System for Human Cytogenetic 
Nomenclature (ISCN), omitting breakpoint information 
either when the quality of counterstained chromosomes 
or the blending of colors through fluorescence flaring 
prevented the accurate definition of breakpoints. 
Chromosomal gains or structural aberrations had to be 
detected in at least two metaphases and chromosomal 
losses in three metaphases to be acknowledged as clonal. 
Chromosome identification and band nomenclature were 
indicated according to the standard rat karyotype [73].
Statistical analyses
Statistical analyses were performed using the Mann-
Whitney nonparametric test for comparison of the means, 
using the Graph-Pad Prism software. A p value < 0.05 
was considered to be statistically significant. All graphs 
present the mean and standard deviations of at least three 
independent experiments.
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